Summary auto-generated
This paper describes the identification and formal characterization of Rickettsia slovaca sp. nov., a spotted fever group rickettsia first isolated from Dermacentor marginatus ticks in Slovakia in 1968. The organism was identified using multiple molecular and phenotypic approaches, including microimmunoflourescence serotyping, monoclonal antibodies, SDS-PAGE analysis, PCR-RFLP of specific genes, pulsed-field gel electrophoresis, and DNA sequencing of 16S rRNA, gltA, and ompA genes. These analyses demonstrated that R. slovaca is genotypically and phenotypically distinct from all other spotted fever group rickettsiae. The species is distributed across Europe following the range of its tick vector and has been found in multiple countries including Slovakia, Czech Republic, France, Switzerland, and Portugal. Recently, R. slovaca has been implicated in human febrile illness, including cases presenting with severe headache, necrotic eschar, lymph node enlargement, and meningoencephalitis. The organism is susceptible to doxycycline and other antibiotics. The authors formally propose R. slovaca as a new species and designate strain B, isolated from D. marginatus ticks, as the type strain.
Key findings
- R. slovaca is a genotypically and phenotypically distinct spotted fever group rickettsia species, demonstrable through multiple molecular and serological methods including gene sequencing and monoclonal antibody analysis
- The organism was isolated from Dermacentor marginatus ticks in Slovakia and is distributed across Europe, with geographic distribution following its tick vector
- R. slovaca has been implicated in human febrile illness including meningoencephalitis and cases with necrotic eschar and lymphadenopathy
- Genetic analysis shows R. slovaca has 32-52% divergence from other spotted fever group rickettsiae, with closest relationship to Thai tick typhus rickettsia
- The species is susceptible to doxycycline (MIC 0.125 µg/mL) and can be used as first-line treatment
This summary was generated automatically from the article PDF and is not part of the original publication. Refer to the PDF for the authoritative text.
Abstract
The name Rickettsia slovaca sp. nov. (type strain is strain B) is proposed for a member of the spotted fever group (SFG) rickettsiae which was isolated from Dermacentor marginatus ticks in Slovakia in 1968, and was recently implicated in human febrile illness. This rickettsia can be phenotypically distinguished from other SFG rickettsiae by microimmunofluorescence serotyping, SDS-PAGE, Western blotting and mAbs. Genotypic differences between R. slovaca and the other SFG representatives can be demonstrated by PCR-RFLP analysis, pulsed-field gel electrophoresis and sequencing of 16S rRNA, gltA and ompA genes.